Loading...
 
Translate Register Log In Login with facebookLogin and Register

UK pediatricians have a lot to learn about vitamin D – May 2012

Presentation and treatment of Vitamin D deficiency

Arch Dis Child 2012;97:A115 doi:10.1136/archdischild-2012-301885.274
British Association of General Paediatrics/British Society for Paediatric Endocrinology & Diabetes
N Subbaraya, N Lygo, J Forster, S Shenoy
Department of Paediatrics, Leicester Royal Infirmary, Leicester, UK
– – – – – – – – –

Summary by VitaminDWiki

After 8 weeks of treatment (how much vitamin D is not stated in abstract)
7% still < 20 nanograms
30% of infants got to range of 80-200 nanograms

Comments by VitaminDWiki

  1. BNF should consider reducing the treatment for infants
  2. They appear to have no maintenance dose – just 8 weeks of treatment, with no follow-up
    Doubt that the treatment given without maintenance does will provide ANY benefit after 1 year.

– – – – – – – – – – – – – – –
Aim To evaluate the adequacy and safety of current recommended dosage of Vitamin D (VitD) treatment in children diagnosed with vitamin D deficiency (vitDD) and role for routine follow-up VitD levels following treatment.

Method Retrospective audit of all children (0-16 years) diagnosed to have VitDD and received treatment, according to local guidelines, during 18 month period (Jan 2010-June 2011). Data on demographics, investigation, treatment and follow-up VitD levels were analysed. Dose of Cholecalciferol was that recommended in children's British National Formulary (cBNF).

Results 137 children fulfilled the criteria. 28% < 6 months age at diagnosis, 22% over 12 years and 50% within 6 m – 12 years age group. 80% (N=117) were South Asian (SA) ethnicity. There was equal distribution of cases throughout the year. 47% had no other underlying medical issues. 44% (N=60) were asymptomatic. 34 infants <6 months age were asymptomatic and diagnosed to have VitDD during prolonged jaundice screening.

Bone pain was the most frequent presenting symptom amongst those symptomatic.

53% were severe deficient (VitD < 15 nmol/l), 32% deficient (15-30 nmol/l) and 15% insufficient (30-50 nmol/l).
{VitaminDWiki: that is, 100% met the criteria, whatever that was. Perhaps < 20nanograms}
There was no significant difference in the severity of deficiency between asymptomatic and symptomatic groups. All received treatment for 8 weeks duration except 9% for 6 weeks (all had insufficiency rather than deficiency). 83% (N = 84) had followup VitD levels after treatment. 93% achieved levels within ‘ideal’ range (50-150 nmol/l) whilst 7% failed to achieve (compliance issue identified in all). 6 of the 20 children under 6 months age had followup level above the ideal range up to 200 nmol/l but not toxic level (> 500 nmol/l).

Conclusions VitDD is very common in children of SA ethnicity. Children with severe VitDD can be asymptomatic. Dose of Cholecalciferol recommended in cBNF for a period of 8 weeks to correct VitDD is safe to use except those under 6 months where a 6 week course is adequate. Routine followup VitD levels after treatment is not necessary unless compliance with treatment is considered and in those children <6 months age until further evidence of safety in this age group.
- - - - - - - - - - -

Some of what UK pediatricians might need to learn

The UK might know some of the following – but such information is not available outside of the UK

  • Identify additional groups of children who are also at high risk
    not just dark skin (e.g. excess fat)
  • Test for a rare allergic reaction to vitamin D before giving high doses.
  • Dose size should increase with the number of high risk categories a child is in
  • Also provide some cofactors, not just vitamin D
  • Followup with maintenance doses after the loading dose.

See also VitaminDWiki

See any problem with this page? Report it (FINALLY WORKS)